Severe fibrosing mediastinitis with atypical presentation: Effective control with novel therapeutic approach

Fibrosing mediastinitis (FM), also known as sclerosing mediastinitis, is an uncommon but serious disease involving the mediastinal structures. A high index of suspicion is essential to establish the diagnosis of FM and starting the appropriate therapy for patients. Here, we report a case of a young...

Full description

Bibliographic Details
Main Authors: Abdulaziz Uthman Joury, Ahmad Amer Al Boukai, Tarek Seifaw Kashour
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Annals of Thoracic Medicine
Subjects:
Online Access:http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2017;volume=12;issue=3;spage=209;epage=212;aulast=Joury
id doaj-67cc819657e34ae0929701bc19b6a64d
record_format Article
spelling doaj-67cc819657e34ae0929701bc19b6a64d2020-11-24T23:15:50ZengWolters Kluwer Medknow PublicationsAnnals of Thoracic Medicine1817-17371998-35572017-01-0112320921210.4103/atm.ATM_47_17Severe fibrosing mediastinitis with atypical presentation: Effective control with novel therapeutic approachAbdulaziz Uthman JouryAhmad Amer Al BoukaiTarek Seifaw KashourFibrosing mediastinitis (FM), also known as sclerosing mediastinitis, is an uncommon but serious disease involving the mediastinal structures. A high index of suspicion is essential to establish the diagnosis of FM and starting the appropriate therapy for patients. Here, we report a case of a young female who presented with chest symptoms and subsequently underwent different laboratory and radiologic investigations and an excisional biopsy. The findings of these investigations were consistent with the diagnosis of idiopathic FM. Her disease was associated with complete occlusion of three pulmonary veins and the left main pulmonary artery. The patient was treated with initial high-dose steroids followed by maintenance steroid and methotrexate therapy with very good long-term disease control. Clinical response, high-sensitivity C-reactive protein, and erythrocyte sedimentation rate were used to monitor disease activity and response to therapy.http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2017;volume=12;issue=3;spage=209;epage=212;aulast=JouryFibrosingmediastinitispulmonarytherapy
collection DOAJ
language English
format Article
sources DOAJ
author Abdulaziz Uthman Joury
Ahmad Amer Al Boukai
Tarek Seifaw Kashour
spellingShingle Abdulaziz Uthman Joury
Ahmad Amer Al Boukai
Tarek Seifaw Kashour
Severe fibrosing mediastinitis with atypical presentation: Effective control with novel therapeutic approach
Annals of Thoracic Medicine
Fibrosing
mediastinitis
pulmonary
therapy
author_facet Abdulaziz Uthman Joury
Ahmad Amer Al Boukai
Tarek Seifaw Kashour
author_sort Abdulaziz Uthman Joury
title Severe fibrosing mediastinitis with atypical presentation: Effective control with novel therapeutic approach
title_short Severe fibrosing mediastinitis with atypical presentation: Effective control with novel therapeutic approach
title_full Severe fibrosing mediastinitis with atypical presentation: Effective control with novel therapeutic approach
title_fullStr Severe fibrosing mediastinitis with atypical presentation: Effective control with novel therapeutic approach
title_full_unstemmed Severe fibrosing mediastinitis with atypical presentation: Effective control with novel therapeutic approach
title_sort severe fibrosing mediastinitis with atypical presentation: effective control with novel therapeutic approach
publisher Wolters Kluwer Medknow Publications
series Annals of Thoracic Medicine
issn 1817-1737
1998-3557
publishDate 2017-01-01
description Fibrosing mediastinitis (FM), also known as sclerosing mediastinitis, is an uncommon but serious disease involving the mediastinal structures. A high index of suspicion is essential to establish the diagnosis of FM and starting the appropriate therapy for patients. Here, we report a case of a young female who presented with chest symptoms and subsequently underwent different laboratory and radiologic investigations and an excisional biopsy. The findings of these investigations were consistent with the diagnosis of idiopathic FM. Her disease was associated with complete occlusion of three pulmonary veins and the left main pulmonary artery. The patient was treated with initial high-dose steroids followed by maintenance steroid and methotrexate therapy with very good long-term disease control. Clinical response, high-sensitivity C-reactive protein, and erythrocyte sedimentation rate were used to monitor disease activity and response to therapy.
topic Fibrosing
mediastinitis
pulmonary
therapy
url http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2017;volume=12;issue=3;spage=209;epage=212;aulast=Joury
work_keys_str_mv AT abdulazizuthmanjoury severefibrosingmediastinitiswithatypicalpresentationeffectivecontrolwithnoveltherapeuticapproach
AT ahmadameralboukai severefibrosingmediastinitiswithatypicalpresentationeffectivecontrolwithnoveltherapeuticapproach
AT tarekseifawkashour severefibrosingmediastinitiswithatypicalpresentationeffectivecontrolwithnoveltherapeuticapproach
_version_ 1725589376514129920